Suppression of tumor angiogenesis by metformin treatment<i>via</i>a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis
Jichang Wang(First Affiliated Hospital of Xi'an Jiaotong University), Peijun Liu(First Affiliated Hospital of Xi'an Jiaotong University)
Cited by 107
Related Papers
Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation
|Journal of Experimental & Clinical Cancer Research|2019|141
Simvastatin suppresses the DNA replication licensing factor MCM7 and inhibits the growth of tamoxifen-resistant breast cancer cells
|Scientific Reports|2017|66
RETRACTED ARTICLE: Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth
|Cell Death and Disease|2017|45